Patenting and Licensing Sample Clauses

Patenting and Licensing. In the event of the Collaboration Tasks resulting in a patentable invention, both Parties shall jointly determine what if any, patent applications shall be made in respect thereof and in which countries such applications shall be made and be responsible for the registration and maintaining of the patent.

Patenting and Licensing. For VA: Department of Veterans Affairs Director, Technology Transfer (12TT) ▇▇▇ ▇▇▇▇▇▇▇ ▇▇ ▇▇ ▇▇▇▇▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇ Email: ▇▇▇.▇▇▇▇▇▇▇▇@▇▇.▇▇▇; Telephone: (▇▇▇) ▇▇▇-▇▇▇▇; Fax: (▇▇▇) ▇▇▇-▇▇▇▇ For Collaborator: AVEO Pharmaceuticals, Inc. ▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇▇ Cambridge, MA 02139 Attn: VP, Intellectual Property VA PII CRADA MODEL 8AUG08 Page 13 of 13 ACCEPTED AND AGREED: By executing this agreement, each Party represents that all statements made herein are true, complete, and accurate to the best of its knowledge; that each has read and understood this CRADA prior to signing; and that each enters into it freely and voluntarily. FOR COLLABORATOR 9/8/11 Date Signature Typed Name Title FOR VA: Signature (NPC Executive Director or Other Authorized Signatory) Date Typed Name Title Principal Investigator Acknowledgement While not a Party, I understand and agree to the Principal Investigator obligations stated in this Agreement. Further, I certify that I am not debarred under subsections 306(a) or (b) of the Federal Food, Drug, and Cosmetic Act and shall not use in any capacity the services of any person debarred under such law with respect to services to be performed under this Agreement. I also certify that I am not excluded from any Federal health care program, including but not limited to Medicare and Medicaid. /s/ ▇▇▇▇ ▇▇▇▇▇▇ Principal Investigator Signature ▇▇▇▇ ▇ ▇▇▇▇▇▇ MD, PhD Principal Investigator Name VA CT CRADA Appendices MODEL 5/2007 Department of Veterans Affairs VA CT CRADA Appendices MODEL 5/2007 Department of Veterans Affairs Symptoms including cachexia (involuntary weight loss), anorexia (decreased appetite and food intake) and poor functional performance affect the majority of patients with cancer. These symptoms are associated with poor prognosis and have a profound impact on the quality of life and return to productivity of these patients. Cachexia is the result of an imbalance between energy intake and energy expenditure and both mechanisms are thought to be affected in the setting of cancer. Current evidence suggests that a proinflammatory state may be responsible for many of the symptoms associated with cancer (1-4). Cytokines are increased in cancer-cachexia patients. IL-6 administration in rodents (5) and humans (6) reduces body weight, increases the resting metabolic rate and suppresses appetite. AVEO Pharmaceuticals is committed to discovering and developing targeted therapies to impact cancer patients’ lives. Using a proprietary Human Respons...

Patenting and Licensing. For VA: For Collaborator:

Patenting and Licensing. Patenting and Licensing of inventions generated by NCI Investigators (whether intramural or extramural) conducting the Research Plan will be managed in a manner consistent with the IP Option. In addition, inventions generated during Secondary Research conducted by investigators, including NIH Intramural Investigators, will be subject to the terms of the IP Option.